Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis.
Saved in:
| Title: | Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis. |
|---|---|
| Authors: | Isufi D; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark., Schwarz CW; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Jensen MB; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, Herlev, Denmark., Seidelin J; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Digestive Diseases and Transplantation, IBD Section, Rigshospitalet, Copenhagen, Denmark., Skov L; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Loft N; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. nikolai.nguyen.loft@regionh.dk.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark. nikolai.nguyen.loft@regionh.dk. |
| Source: | Clinical and experimental medicine [Clin Exp Med] 2025 Jun 25; Vol. 25 (1), pp. 219. Date of Electronic Publication: 2025 Jun 25. |
| Publication Type: | Journal Article; Meta-Analysis; Systematic Review |
| Journal Info: | Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40560239 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Isufi+D%22">Isufi D</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Schwarz+CW%22">Schwarz CW</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Jensen+MB%22">Jensen MB</searchLink>; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Dermatology and Allergy, National Allergy Research Centre, Herlev and Gentofte Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Seidelin+J%22">Seidelin J</searchLink>; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Digestive Diseases and Transplantation, IBD Section, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Skov+L%22">Skov L</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Loft+N%22">Loft N</searchLink>; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. nikolai.nguyen.loft@regionh.dk.; Copenhagen Research Group for Inflammatory Skin, Herlev and Gentofte Hospital, Herlev, Denmark. nikolai.nguyen.loft@regionh.dk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100973405%22">Clinical and experimental medicine</searchLink> [Clin Exp Med] 2025 Jun 25; Vol. 25 (1), pp. 219. <i>Date of Electronic Publication: </i>2025 Jun 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Meta-Analysis; Systematic Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Italia%22">Springer-Verlag Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>100973405 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1591-9528 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215918890%22">15918890 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40560239 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10238-025-01738-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 219 Titles: – TitleFull: Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Isufi D – PersonEntity: Name: NameFull: Schwarz CW – PersonEntity: Name: NameFull: Jensen MB – PersonEntity: Name: NameFull: Seidelin J – PersonEntity: Name: NameFull: Skov L – PersonEntity: Name: NameFull: Loft N IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 06 Text: 2025 Jun 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1591-9528 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Clinical and experimental medicine Type: main |
| ResultId | 1 |
